Companies
Intel’s 18A Process Faces Mixed Signals as Nvidia, Broadcom Test Manufacturing Capabilities
Intel (INTC) has gained early interest from major chip designers Nvidia (NVDA) and Broadcom (AVGO), as the two companies conduct...
Dell Stock Dips After Soft Guidance, But Analysts See Buying Opportunity
Dell Technologies saw its shares decline on Friday following a weaker-than-expected revenue outlook, but analysts suggest the dip could be...
Amazon Unveils First Quantum Computing Chip Amid Rising Industry Competition
Amazon (AMZN) has introduced its first quantum computing chip, Ocelot, marking a significant step in the ongoing race to develop...
NVIDIA Posts Record Revenue as AI Demand Soars
Data Center Growth and AI Innovation Drive Strong Q4 and Full-Year Performance NVIDIA (NVDA) continues its meteoric rise, reporting record-breaking...
GM Boosts Shareholder Returns with Dividend Hike and $6 Billion Buyback Plan
Automaker responds to investor demands with accelerated share repurchase program General Motors (GM) is delivering for its shareholders, announcing a...
Perfect Corp. Reports Strong 2024 Growth Driven by AI and AR Innovations
Record Revenue Growth and Expansion Signal Promising 2025 Outlook Perfect Corp (PERF), a global leader in AI and AR SaaS...
CAVA Group Reports Strong Fiscal 2024 Growth, Driven by Same Restaurant Sales and Expansion
Mediterranean Fast-Casual Chain Achieves 35.1% Revenue Growth and Expands Footprint CAVA Group (CAVA) delivered another year of impressive growth in...
Nvidia and Cisco Expand Partnership to Simplify AI Adoption
Tech Giants Aim to Help Businesses Overcome AI Deployment Challenges Nvidia (NVDA) and Cisco Systems (CSCO) are strengthening their collaboration...
Bitcoin Plunges Below $90K as Tariffs, Hacks, and Scandals Shake Crypto Markets
Investor Confidence Wanes Amid Trump’s Trade Policies and Industry Setbacks Bitcoin (BTC.X) fell below $90,000 on Tuesday, marking its lowest...
Hims & Hers Health Faces Crucial Earnings Test Amid Stock Volatility
Meme-Stock Frenzy Collides with Regulatory Uncertainty and Investor Skepticism Hims & Hers Health (HIMS) is at a crossroads as it...
